Risk factors of COVID-19 breakthrough infection
We aimed to identify risk factors for breakthrough SARS-CoV-2 infection after at least one dose of any COVID-19 vaccine. This is a case-control test-negative design study in hospitalized patients with a severe acute respiratory infection, at least one dose of any COVID-19 vaccine and a PCR-test for...
| Autores: | , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:dnet:uabarcelona_::94653405a7a140600a788cebd03d8b21 |
| Acceso en línea: | https://ddd.uab.cat/record/328082 https://dx.doi.org/urn:doi:10.1186/s12879-025-11773-x |
| Access Level: | acceso abierto |
| Palabra clave: | Risk factors COVID-19 Breakthrough infection Vaccines |
| id |
ES_c7a5cdf6c2e9fd9d1d7cb4dc4acacb73 |
|---|---|
| oai_identifier_str |
oai:dnet:uabarcelona_::94653405a7a140600a788cebd03d8b21 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Risk factors of COVID-19 breakthrough infectiona case-control test-negative design studyOtero-Romero, Susana|||0000-0002-6798-568XBorras Bermejo, Blanca|||0000-0003-4111-5632Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815Andrés, Cristina|||0000-0002-3200-0895Tejada-Panduro, Gabriela|||0000-0002-8948-005XPinós-Tella, LaiaCarbones, IngridParés-Badell, OleguerRisk factorsCOVID-19Breakthrough infectionVaccinesWe aimed to identify risk factors for breakthrough SARS-CoV-2 infection after at least one dose of any COVID-19 vaccine. This is a case-control test-negative design study in hospitalized patients with a severe acute respiratory infection, at least one dose of any COVID-19 vaccine and a PCR-test for SARS-CoV-2/COVID-19 performed between 1 November 2021 and 28 June 2022. Cases and controls were matched by age and date of test. A logistic regression model with adjusted odds ratios was performed to determine factors related to breakthrough infection. We analyzed 1,340 breakthrough SARS-CoV-2 infections matched with 4,016 controls. After adjustment, the odds of a breakthrough infection were 64% higher in patients whose last vaccine dose was administered more than 6 months before hospitalization compared to those vaccinated within the previous 6 months (aOR 1.64; CI 95% 1.42-1.88). Moreover, immunosuppression was statistically associated with breakthrough infection (aOR 2.04; CI 95%, 1.58-2.62). The probability of breakthrough SARS-CoV-2 infection was significantly higher in hospitalized patients who had received their last vaccine dose more than six months before hospitalization; while immunosuppression was the most important risk factor for breakthrough infection. The online version contains supplementary material available at 10.1186/s12879-025-11773-x. 22025-01-0120252025-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/328082https://dx.doi.org/urn:doi:10.1186/s12879-025-11773-xreponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:dnet:uabarcelona_::94653405a7a140600a788cebd03d8b212026-06-06T12:50:31Z |
| dc.title.none.fl_str_mv |
Risk factors of COVID-19 breakthrough infection a case-control test-negative design study |
| title |
Risk factors of COVID-19 breakthrough infection |
| spellingShingle |
Risk factors of COVID-19 breakthrough infection Otero-Romero, Susana|||0000-0002-6798-568X Risk factors COVID-19 Breakthrough infection Vaccines |
| title_short |
Risk factors of COVID-19 breakthrough infection |
| title_full |
Risk factors of COVID-19 breakthrough infection |
| title_fullStr |
Risk factors of COVID-19 breakthrough infection |
| title_full_unstemmed |
Risk factors of COVID-19 breakthrough infection |
| title_sort |
Risk factors of COVID-19 breakthrough infection |
| dc.creator.none.fl_str_mv |
Otero-Romero, Susana|||0000-0002-6798-568X Borras Bermejo, Blanca|||0000-0003-4111-5632 Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815 Andrés, Cristina|||0000-0002-3200-0895 Tejada-Panduro, Gabriela|||0000-0002-8948-005X Pinós-Tella, Laia Carbones, Ingrid Parés-Badell, Oleguer |
| author |
Otero-Romero, Susana|||0000-0002-6798-568X |
| author_facet |
Otero-Romero, Susana|||0000-0002-6798-568X Borras Bermejo, Blanca|||0000-0003-4111-5632 Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815 Andrés, Cristina|||0000-0002-3200-0895 Tejada-Panduro, Gabriela|||0000-0002-8948-005X Pinós-Tella, Laia Carbones, Ingrid Parés-Badell, Oleguer |
| author_role |
author |
| author2 |
Borras Bermejo, Blanca|||0000-0003-4111-5632 Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815 Andrés, Cristina|||0000-0002-3200-0895 Tejada-Panduro, Gabriela|||0000-0002-8948-005X Pinós-Tella, Laia Carbones, Ingrid Parés-Badell, Oleguer |
| author2_role |
author author author author author author author |
| dc.subject.none.fl_str_mv |
Risk factors COVID-19 Breakthrough infection Vaccines |
| topic |
Risk factors COVID-19 Breakthrough infection Vaccines |
| description |
We aimed to identify risk factors for breakthrough SARS-CoV-2 infection after at least one dose of any COVID-19 vaccine. This is a case-control test-negative design study in hospitalized patients with a severe acute respiratory infection, at least one dose of any COVID-19 vaccine and a PCR-test for SARS-CoV-2/COVID-19 performed between 1 November 2021 and 28 June 2022. Cases and controls were matched by age and date of test. A logistic regression model with adjusted odds ratios was performed to determine factors related to breakthrough infection. We analyzed 1,340 breakthrough SARS-CoV-2 infections matched with 4,016 controls. After adjustment, the odds of a breakthrough infection were 64% higher in patients whose last vaccine dose was administered more than 6 months before hospitalization compared to those vaccinated within the previous 6 months (aOR 1.64; CI 95% 1.42-1.88). Moreover, immunosuppression was statistically associated with breakthrough infection (aOR 2.04; CI 95%, 1.58-2.62). The probability of breakthrough SARS-CoV-2 infection was significantly higher in hospitalized patients who had received their last vaccine dose more than six months before hospitalization; while immunosuppression was the most important risk factor for breakthrough infection. The online version contains supplementary material available at 10.1186/s12879-025-11773-x. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2 2025-01-01 2025 2025-01-01 |
| dc.type.none.fl_str_mv |
Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://ddd.uab.cat/record/328082 https://dx.doi.org/urn:doi:10.1186/s12879-025-11773-x |
| url |
https://ddd.uab.cat/record/328082 https://dx.doi.org/urn:doi:10.1186/s12879-025-11773-x |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona |
| instname_str |
Universitat Autònoma de Barcelona |
| reponame_str |
Dipòsit Digital de Documents de la UAB |
| collection |
Dipòsit Digital de Documents de la UAB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869419196754952192 |
| score |
15.812455 |